Literature DB >> 25175483

Differential expression of stem cell markers and ABCG2 in recurrent prostate cancer.

Esra Guzel1, Omer F Karatas, Mehmet B Duz, Mustafa Solak, Michael Ittmann, Mustafa Ozen.   

Abstract

BACKGROUND: Prostate cancer (PCa) is the second most common tumor type related to mortality in males in the developed countries. Studies have demonstrated that therapeutic tools mostly ineffective to give positive outcome especially for PCa. Cancer stem cells are composed of a small cell population, which are supposed to have roles in tumorigenesis, metastasis, and tumor recurrence after chemo-radiotherapy. The aim of this research is to investigate expressions of stem cell markers in recurrent PCa and non-recurrent PCa tumors as well as in adjacent normal prostate tissues.
METHODS: We compared the expression of important stemness regulators like SOX2, OCT4, KLF4, and ABCG2 in recurrent, non-recurrent PCa and adjacent normal tissue samples using quantitative real-time polymerase chain reaction (qRT-PCR).
RESULTS: Our results demonstrated that SOX2 and OCT4 are strongly overexpressed in PCa samples. Recurrent PCa samples are markedly positive for stem cell markers SOX2, OCT4, and KLF4. Furthermore, non-recurrent PCa samples presented low levels of ABCG2, a multidrug resistance protein, compared to both normal and recurrent samples, which might be associated with chemo-sensitivity.
CONCLUSIONS: Enhanced expression of ABCG2 and stem cell markers including SOX2, OCT4, and KLF4 in the recurrent PCa tissues postulates the suggestion that enrichment for cells with stem cell characteristics in these tissues might be playing a critical role for chemoresistance and recurrence of cancer.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  chemoresistance; prostate cancer; recurrence; stem cell markers

Mesh:

Substances:

Year:  2014        PMID: 25175483     DOI: 10.1002/pros.22867

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  21 in total

1.  Imbalance of a KLF4-miR-7 auto-regulatory feedback loop promotes prostate cancer cell growth by impairing microRNA processing.

Authors:  Lian-Zi Wei; Yan-Qing Wang; Yun-Li Chang; Na An; Xiao Wang; Pei-Jie Zhou; Helen He Zhu; Yu-Xiang Fang; Wei-Qiang Gao
Journal:  Am J Cancer Res       Date:  2018-02-01       Impact factor: 6.166

2.  Genome-wide differentially methylated genes in prostate cancer tissues from African-American and Caucasian men.

Authors:  J M Devaney; S Wang; P Furbert-Harris; V Apprey; M Ittmann; B-D Wang; J Olender; N H Lee; B Kwabi-Addo
Journal:  Epigenetics       Date:  2015-04-11       Impact factor: 4.528

3.  Transcription factor Oct4 promotes osteosarcoma by regulating lncRNA AK055347.

Authors:  Hongwu Fan; Guangyao Liu; Changfu Zhao; Xuefeng Li; Xiaoyu Yang
Journal:  Oncol Lett       Date:  2016-11-21       Impact factor: 2.967

Review 4.  Metformin and prostate cancer stem cells: a novel therapeutic target.

Authors:  M J Mayer; L H Klotz; V Venkateswaran
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-07-28       Impact factor: 5.554

5.  A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells.

Authors:  Yiming Zhang; Yiqiang Huang; Zhong Jin; Xiezhao Li; Bingkun Li; Peng Xu; Peng Huang; Chunxiao Liu
Journal:  Tumour Biol       Date:  2016-04-25

6.  Deregulation of MiR-34b/Sox2 Predicts Prostate Cancer Progression.

Authors:  Irene Forno; Stefano Ferrero; Maria Veronica Russo; Giacomo Gazzano; Sara Giangiobbe; Emanuele Montanari; Alberto Del Nero; Bernardo Rocco; Giancarlo Albo; Lucia R Languino; Dario C Altieri; Valentina Vaira; Silvano Bosari
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

Review 7.  Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication.

Authors:  Samantha Kaufhold; Hermes Garbán; Benjamin Bonavida
Journal:  J Exp Clin Cancer Res       Date:  2016-05-25

8.  Frequent down-regulation of ABC transporter genes in prostate cancer.

Authors:  Rita Demidenko; Deividas Razanauskas; Kristina Daniunaite; Juozas Rimantas Lazutka; Feliksas Jankevicius; Sonata Jarmalaite
Journal:  BMC Cancer       Date:  2015-10-12       Impact factor: 4.430

Review 9.  Current Stem Cell Biomarkers and Their Functional Mechanisms in Prostate Cancer.

Authors:  Kaile Zhang; Shukui Zhou; Leilei Wang; Jianlong Wang; Qingsong Zou; Weixin Zhao; Qiang Fu; Xiaolan Fang
Journal:  Int J Mol Sci       Date:  2016-07-19       Impact factor: 5.923

10.  Hepatocellular carcinoma stem cell-like cells are enriched following low-dose 5-fluorouracil chemotherapy.

Authors:  Yongqiang Zhan; Lisha Mou; Kangwen Cheng; Chengyou Wang; Xuesong Deng; Junren Chen; Zhibing Fan; Yong Ni
Journal:  Oncol Lett       Date:  2016-08-08       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.